MeSH term
Count | Dopamine Agonists/*therapeutic use | 29 |
Dopamine Agonists/therapeutic use | 12 |
Dopamine Agonists/diagnostic use/therapeutic use | 1 |
Dopamine Agonists/pharmacology/therapeutic use | 1 |
Dopamine Agonists/adverse effects/therapeutic use | 1 |
Dopamine Agonists/administration & dosage/*therapeutic use | 3 |
Dopamine Agonists/adverse effects/*therapeutic use | 3 |
Dopamine Agonists/adverse effects/*pharmacokinetics/therapeutic use | 1 |
Dopamine Agonists/administration & dosage/pharmacology/*therapeutic use | 1 |
Dopamine Agonists | 3 |
Receptors, Dopamine D2/agonists | 1 |
Dopamine Agonists/pharmacokinetics | 1 |
Dopamine Agonists/*pharmacokinetics | 1 |
Dopamine Agonists/*metabolism | 3 |
Dopamine Agonists/metabolism | 3 |
Dopamine Agonists/*pharmacology | 12 |
Dopamine Agonists/pharmacology | 18 |
Receptors, Dopamine D2/*agonists | 3 |
Dopamine Agonists/*urine | 1 |
Dopamine Agonists/*administration & dosage | 3 |
Dopamine Agonists/administration & dosage | 1 |
Receptors, Dopamine D2/agonists/*biosynthesis/genetics | 1 |
Receptors, Dopamine D2/*agonists/metabolism/*physiology | 1 |
Dopamine Agonists/adverse effects/*pharmacology | 1 |
Receptors, Dopamine D1/agonists/antagonists & inhibitors/*metabolism | 1 |
Receptors, Dopamine D2/agonists/antagonists & inhibitors/*metabolism | 2 |
Dopamine Agonists/administration & dosage/*pharmacokinetics/*pharmacology | 1 |
Dopamine Agonists/*administration & dosage/adverse effects | 1 |
Receptors, Dopamine D2/agonists/antagonists & inhibitors/metabolism | 1 |
Dopamine Agonists/chemical synthesis/chemistry/metabolism/pharmacology | 1 |
Dopamine/*therapeutic use | 2 |
Dopamine/therapeutic use | 5 |
Dopamine Antagonists/*therapeutic use | 4 |
Dopamine Antagonists/therapeutic use | 3 |
Dopamine/metabolism/*therapeutic use | 1 |
Dopamine/pharmacology/therapeutic use | 1 |
Dopamine Agents/therapeutic use | 9 |
Dopamine Agents/*therapeutic use | 9 |
Dopamine Antagonists/blood/*therapeutic use | 2 |
Dopamine/pharmacology/physiology/*therapeutic use | 1 |
Dopamine Uptake Inhibitors/*therapeutic use | 1 |
Dopamine/administration & dosage/*therapeutic use | 1 |
Dopamine Antagonists/*pharmacology/therapeutic use | 1 |
Dopamine/analogs & derivatives/*pharmacology/therapeutic use | 1 |
Dopamine Antagonists/*adverse effects/therapeutic use | 1 |
Dopamine Antagonists/adverse effects/*therapeutic use | 1 |
Dopamine Agents/administration & dosage/*therapeutic use | 3 |
Dopamine Agents/adverse effects/*therapeutic use | 5 |
Dopamine Agents/administration & dosage/blood/*therapeutic use | 1 |
Dopamine Agents/adverse effects/standards/*therapeutic use | 1 |
Myeloablative Agonists/therapeutic use | 4 |
Histamine Agonists/*therapeutic use | 1 |
Histamine Agonists/therapeutic use | 3 |
Cholinergic Agonists/*therapeutic use | 1 |
Serotonin Agonists/therapeutic use | 2 |
Serotonin Agonists/*therapeutic use | 1 |
Muscarinic Agonists/*therapeutic use | 1 |
Gonadorelin/*agonists/*therapeutic use | 1 |
Calcium Channel Agonists/*therapeutic use | 3 |
Calcium Channel Agonists/therapeutic use | 2 |
Adrenergic beta-Agonists/therapeutic use | 5 |
Serotonin Agonists/pharmacology/therapeutic use | 1 |
Adrenergic alpha-Agonists/*therapeutic use | 1 |
Adrenergic beta-Agonists/*therapeutic use | 10 |
Androgens/agonists/chemistry/*therapeutic use | 2 |
Serotonin Agonists/*pharmacology/therapeutic use | 2 |
Adrenergic alpha-Agonists/therapeutic use | 7 |
Serotonin Agonists/administration & dosage/*therapeutic use | 1 |
Adrenergic alpha-Agonists/*pharmacology/therapeutic use | 1 |
Muscarinic Agonists/administration & dosage/*therapeutic use | 1 |
Calcium Channel Agonists/pharmacology/*therapeutic use | 1 |
Receptors, Somatostatin/agonists/genetics/*therapeutic use | 1 |
Gonadorelin/adverse effects/agonists/therapeutic use | 1 |
Serotonin Agonists/*adverse effects/therapeutic use | 1 |
Adrenergic beta-Agonists/*pharmacology/therapeutic use | 1 |
Adrenergic beta-Agonists/pharmacology/*therapeutic use | 1 |
Adrenergic alpha-Agonists/pharmacology/*therapeutic use | 1 |
Adrenergic beta-Agonists/*administration & dosage/therapeutic use | 2 |
Adrenergic alpha-Agonists/adverse effects/*therapeutic use | 1 |
Interleukin-2/agonists/*analogs & derivatives/physiology/*therapeutic use | 1 |
Excitatory Amino Acid Agonists/metabolism/therapeutic use | 1 |
*Serotonin Agonists/administration & dosage/economics/therapeutic use | 1 |
Adrenergic beta-Agonists/administration & dosage/*therapeutic use | 1 |
Nerve Growth Factors/agonists/metabolism/pharmacology/*therapeutic use | 1 |
Brain-Derived Neurotrophic Factor/agonists/*physiology/therapeutic use | 1 |
Dopamine | 5 |
*Dopamine | 1 |
Dopamine/*biosynthesis | 13 |
Dopamine/*toxicity | 1 |
*Dopamine/physiology | 1 |
Dopamine/deficiency | 3 |
Receptors, Dopamine D2 | 15 |
Dopamine/*genetics | 13 |
Dopamine/metabolism | 122 |
Dopamine/physiology | 54 |
Dopamine/toxicity | 1 |
Dopamine/pharmacokinetics | 1 |
Dopamine/*secretion | 1 |
*Receptors, Dopamine D2 | 23 |
Dopamine/*urine | 3 |
